11β-Hydroxysteroid dehydrogenase types 1 and 2 (11βHSD1 and 11βHSD2) are two isoenzymes that convert inactive glucocorticoids (e.g., cortisone) to their active forms (e.g., Cortisol) and vice versa. Abundant evidence indicates that 11βHSD2 is expressed as mRNA and protein in both adrenal cortex and adrenal tumors. In contrast, 11βHSD1 has been investigated to a much lesser degree. We therefore studied and compared the expression and activity of the two isoenzymes in the human adrenal cortex (HAC) and cortisol-secreting adenomas (CSAs).
Methods
Six HAC and six CSA specimens were studied. 11βHSD1 and 11βHSD2 gene expression was studied by conventional and semiquantitative reverse transcription-polymer-ase chain reaction. 11βHSD1 and 11βHSD2 activity was assayed by measuring the capacity of both microsomal fraction and tissue fragments to convert [3H]cortisone to [3H]cortisol and vice versa. Steroid hormones were separated and purified by high-performance liquid chromatography, and Cortisol concentration was measured by radioimmunoassay.
Results
Semiquantitative reverse transcription-polymer-ase chain reaction and enzymatic assay demonstrated higher 11βHSD1 expression and activity and lower 11βHSD2 expression and activity in CSAs than in HACs. CSA slices secreted larger amounts of Cortisol than did HAC specimens, and the cholesterol side-chain-cleaving enzyme inhibitor ami-noglutethimide, by blocking the early step of steroid synthesis, reduced Cortisol secretion by approximately 70%. Ami-noglutethimide decreased [3H]cortisol production from [3H]cortisone and increased [3H]cortisone production from [3H]cortisol in both tissues, thereby annulling differences in 11βHSD1 and 11βHSD2 activity between HACs and CSAs.
Conclusion
Collectively, our findings indicate that 1) both 11βHSD isoenzymes are expressed as mRNA and proteins in the HAC and CSA, with 11βHSD1 upregulated and 11βHSD2 downregulated in CSAs; and 2) 11βHSD1 and 11βHSD2 activity is positively and negatively correlated with the intracellular concentration of steroid hormones. Hence, 11βHSD isoenzymes could act as amplifiers of the secreta-gogue effect of agonists and could contribute to the elevated hormonal secretion of CSAs.
RickettsMLVerhaegJMBujalskaIHowieAJRaineyWEStewartPM.Immunohistochemical localization of type 1 11β-hydroxysteroid dehydrogenase in human tissues.J Clin Endocrinol Metab1998; 83: 1325–1335.
3.
JamiesonAWallaceAMAndrewRNunezBSWalkerBRFraserRWhitePCConnellJM.Apparent cortisone reductase deficiency: A functional defect in 11β-hydroxysteroid dehydrogenase type 1.J Clin Endocrinol Metab1999; 84: 3570–3574.
4.
NordenströmAMarcusCAxelsonMWedellARitzenEM.Failure of cortisone acetate treatment in congenital adrenal hyperplasia because of defective 11β-hydroxysteroid dehydrogenase reductase activity.J Clin Endocrinol Metab1999; 84: 1210–1213.
5.
TomlinsonJWDraperNMackieJJohnsonAPHolderGWoodPStewartPM.Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to Cortisol conversion.J Clin Endocrinol Metab2002; 87: 57–62.
6.
MazzocchiGRossiGPNeriGMalendowiczLKAlbertinGNussdorferGG11β-hydoxysteroid dehydrogenase expression and activity in the human adrenal cortex.FASEB J1998; 12: 1533–1539.
TortorellaCAragonaFNussdorferGG.In vivo evidence that human adrenal glands possess 11β-hydroxysteroid dehydrogenase activity.Life Sci1999; 65: 2823–2827.
9.
CoulterCLSmithREStowasserMSasanoHKrozowskiZSGordonRD.Expression of 11βHSD-2 in human adrenal cortical carcinoma and adenoma.Endocr Res1998; 24: 875–876.
10.
CoulterCLSmithREStowasserMSasanoHKrozowskiZSGordonRD.Expression of 11β-hydroxysteroid dehydrogenase type 2 (11βHSD-2) in the developing human adrenal gland and human adrenal cortical carcinoma and adenoma.Mol Cell Endocrinol1999; 154: 71–77.
11.
MazzocchiGAndreisPGDe CaroR, AragonaF, GottardoL, NussdorferGG.Cerebellin enhances in vitro secretory activity of human adrenal gland.J Clin Endocrinol Metab1999; 84: 632–635.
12.
McNicolAM.The human adrenal gland: Aspects of structure, function, and pathology. In JamesVHT (ed): The Adrenal Gland.New York: Raven Press, 1992, ed 2, pp 1–42.
13.
MackinnonMSutherlandESimonFR.Effects of ethinyl estradiol on hepatic microsomal proteins and the turnover of cytochrome P-450.J Lab Clin Med1977; 90: 1096–1106.
14.
MonderCLakshmiVMiroffY.Kinetic studies on rat liver 11β-hydroxysteroid dehydrogenase.Biochim Biophys Acta1991; 1115: 23–29.
15.
NeriGAndreisPGPrayer-GalettiTRossiGPMalendowiczLKNussdorferGG.Pituitary adenylate-cyclase activating peptide enhances aldosterone secretion of human adrenal gland: Evidence for an indirect mechanism, probably involving the local release of catecholamines.J Clin Endocrinol Metab1996; 81: 169–173.
16.
DexterRNFishmanLMNeyRLLiddleGW.Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: Studies of the mechanism of action.J Clin Endocrinol Metab1967; 27: 473–480.
17.
RossiGPAndreisPGNeriGTortorellaCPelizzoMRSac-chettoANussdorferGG.Endothelin-1 stimulates aldosterone synthesis in Conn's adenomas via both A and B receptors coupled with the protein kinase C- and cyclooxygenase-dependent signaling pathways.J Investig Med2000; 48: 343–350.
